FOXO4-DRI

FOXO4-DRI 10MG

Cellular Senescence. Healthy Aging Research. Cellular Renewal.

FOXO4-DRI is an experimental research peptide primarily studied in the field of cellular senescence and biological aging.

It was developed to investigate interactions involving FOXO4 and p53, two proteins involved in cellular stress responses, survival, and apoptosis. Research has explored whether disrupting this interaction may selectively influence senescent cells — aged or damaged cells that have stopped dividing but remain metabolically active within tissues.

Because the accumulation of senescent cells is associated with aging and age-related changes in tissue function, FOXO4-DRI has attracted interest as a potential senolytic research compound.

Rather than simply targeting the outward signs of aging, FOXO4-DRI research focuses on one of the cellular processes being investigated as part of biological aging and tissue homeostasis.

Why It’s Used

• Research involving cellular senescence
• Explore mechanisms associated with biological aging
• Study FOXO4 and p53 signaling pathways
• Investigate senescent-cell survival and apoptosis
• Explore cellular stress-response mechanisms
• Research tissue homeostasis and cellular renewal
• Investigate emerging senolytic pathways

Expected Research Focus

• Cellular senescence
• Senescent-cell clearance mechanisms
• FOXO4–p53 interactions
• Cellular apoptosis pathways
• Biological aging mechanisms
• Cellular stress responses
• Tissue homeostasis and regeneration
• Longevity-related cellular research

Formula

FOXO4-DRI — 10mg

Synthetic D-retro-inverso research peptide investigated for its interaction with FOXO4/p53 signaling and its potential influence on senescent-cell survival pathways.

Category

Longevity / Senescence / Cellular Aging Research

The Problem

As organisms age, senescent cells can accumulate within tissues.

Although cellular senescence serves important biological functions — including limiting the proliferation of damaged cells — persistent accumulation of senescent cells is being investigated for its relationship with chronic inflammatory signaling, altered tissue function, and age-associated biological changes.

FOXO4-DRI research explores whether targeting molecular interactions that help certain senescent cells resist apoptosis could provide a way to study selective senescent-cell clearance and cellular aging pathways.

What It Supports

Research involving cellular senescence, FOXO4/p53 signaling, apoptosis, senolytic mechanisms, cellular stress responses, tissue homeostasis, and biological aging pathways.

Potential Side Effects

FOXO4-DRI remains an experimental compound with very limited human safety data.

Potential adverse effects, appropriate exposure levels, contraindications, drug interactions, and long-term consequences have not been adequately established in controlled human clinical trials.

Because senescence and apoptosis are fundamental biological processes, altering these pathways may also carry risks that are not yet understood.

Disclaimer

For research, educational, or provider-directed use only.

FOXO4-DRI is an investigational research compound. It has not been approved for the diagnosis, treatment, cure, or prevention of any disease.

Research involving FOXO4-DRI remains primarily preclinical, and findings from laboratory or animal studies should not be interpreted as established benefits in humans.